Fig. 1From: Evaluation of tumour heterogeneity by 18F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatmentPatient flowchart for inclusion and exclusion. Abbreviations: HER-2, human epidermal growth receptor 2; ECOG, Eastern Cooperative Oncology GroupBack to article page